Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Window trial of AZD8931 in resectable non-small cell lung cancer
2011-001518-33Phase 2Terminated
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sapitinib in non-small cell lung cancer (NSCLC), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Reduction in Ki-67 proliferation index. Started Jul 2012; status: terminated.
02
Drugs
sapitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2011-001518-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001518-33.